Molecular Devices opens custom-built site in Cardiff for manufacturing of patient-derived organoids

FHS
June 8, 2024
11:32 am

Today, Molecular Devices, LLC., a leading high-performance life science solutions provider, officially opened its custom-built site in Cardiff, UK.

Apnimed hires Pfizer, Biohaven veteran as chief commercial officer

Apnimed named a new chief commercial officer on Monday, tapping Graham Goodrich, a veteran biopharma marketing executive, to start building out a team to commercialize

January 23, 2024

Novel cholesterol removal strategy shows potential benefits post-heart attack

The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within

April 8, 2024

Cholesterol crystals linked to diabetic retinopathy

Advancements that could lead to earlier diagnosis and treatment for diabetic retinopathy, a common complication that affects the eyes, have been identified by a multi-department

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.